FDA's New Generic Drug Safety Labeling Rule
FDA's Generic Drug Safety Labeling Rule
Your office, Dec. 9, 2013
Benefits
Here’s a suggested list of potential participants from your organization:
- Regulatory affairs and compliance officers
- Pharmacovigilance and drug safety personnel and managers
- Medical affairs/medical monitors and physicians
- CCDS writers and reviewers
- Drug safety scientists/risk management specialists
- Consultants/service providers
- Executive management